How Does Xofigo Work for Prostate Cancer? Xofigo is a radioactive medicine that works by providing radiation to your bones. The active radiation ingredient in Xofigo acts like calcium and attaches ...

What is Xofigo used for? Xofigo (radium RA 223 dichloride) is commonly used for prostate cancer that is no longer responding to hormone treatments and has spread to a bone in your body but has not ...

Despite the fact that it has been three years since the drug was approved by the FDA, many oncologists still need to be educated regarding Xofigo's benefits beyond pain palliation, The ...

Final results for the key secondary endpoint of overall survival (OS) from the PEACE-3 trial will be presented by the European Organization for Research and Treatment of Cancer (EORTC) coalition as an ...

Oslo, Norway, 15 November 2013 - Algeta ASA (OSE: ALGETA) announces today that Bayer has received marketing authorisation from the European Commission for Xofigo ® (radium Ra 223 dichloride) solution ...

The HealthCare segment at Bayer (BAYRY) received encouraging news when the European Commission (EC) cleared its oncology drug, Xofigo. Xofigo was approved in the EU for treating adults suffering from ...

US-based Bayer Healthcare Pharmaceuticals, as its executives were quick to point out, has now received three new approvals for cancer indications in the last eight months US-based Bayer Healthcare ...

Brits in search of Bayer’s prostate cancer drug Xofigo or Sanofi’s colorectal drug Zaltrap should prepare for disappointment: the National Institute for Health and Care Excellence has said neither of ...

The HealthCare segment at Bayer ( BAYRY) received encouraging news when the European Commission (EC) cleared its oncology drug, Xofigo. Xofigo was approved in the EU for treating adults suffering from ...